BROADWAY FINANCIAL CORP quarterly report, Q2 FY2018

Broadway Financial Corporation — Q2 2018 Form 10-Q

Reporting period: Quarter and six months ended June 30, 2018; unaudited consolidated results. Broadway Financial is a bank holding company whose principal subsidiary is Broadway Federal Bank. Unless stated otherwise, financial amounts below are in U.S. dollars.

Financial performance

MetricQ2 2018Q2 2017Six months 2018Six months 2017
Net interest income$2.572m$3.002m$5.346m$6.081m
Net income (loss)($127k)$533k($211k)$1.765m
Basic/diluted EPS$0.00$0.02($0.01)$0.07
Non-interest income$170k$322k$301k$1.681m
Non-interest expense$2.923m$2.668m$5.955m$5.711m
Net interest margin2.62%2.72%2.70%2.80%

Q2 net interest income fell $430k year over year, mainly on lower loan interest income; six-month net interest income declined $735k. Lower average earning assets and lower loan yields contributed to the decline, while deposit costs rose. The quarterly loss was $127k; the filing reports quarterly EPS rounded to $0.00.

Financial position, cash flow and credit

  • Assets and loans: Total assets were $412.1m at June 30, down $1.6m from year-end 2017. Net held-for-investment loans rose to $364.8m from $334.9m; held-for-sale loans fell to $1.1m from $22.4m, including a $16.9m transfer into the investment portfolio.
  • Deposits and borrowings: Deposits declined $20.0m to $271.3m, while FHLB advances increased $19.0m to $84.0m. Junior subordinated debentures remained $5.1m. The FHLB advance weighted-average rate was 2.31% at period-end, versus 1.86% at year-end.
  • Liquidity and cash flow: Cash and cash equivalents were $13.6m, down $8.6m from year-end. For the six months, operating cash flow was positive $4.8m, investing cash flow negative $12.3m and financing cash flow negative $1.1m. The Bank reported $16.0m of unpledged available-for-sale securities, up to $21.8m of additional FHLB borrowing capacity subject to collateral and stock requirements, and an $11.0m line of credit.
  • Capital: Stockholders’ equity was $47.3m, or 11.48% of assets; book value was $1.73 per share. The Bank exceeded regulatory minimums and was above “well capitalized” thresholds, with a 19.28% total capital ratio and 11.98% leverage ratio.
  • Credit: The allowance for loan losses was $4.183m, or 1.13% of gross held-for-investment loans. No loan charge-offs or past-due loans were reported at June 30; non-performing loans were $1.247m, down from $1.766m at year-end. TDRs totaled $8.2m, of which $0.9m were non-accrual. Management said the allowance was adequate but cautioned actual losses could exceed estimates.

Changes, outlook and risks

  • Year-over-year earnings comparisons were affected by favorable 2017 items that did not recur: a $1.2m insurance litigation settlement in the first half, loan-loss provision recaptures of $300k in Q2 and $650k for six months, and a $700k reversal of a deferred-compensation liability. Q2 2017 also included $139k of expenses tied to U.S. Treasury stock sales.
  • Management attributed lower loan interest income in Q2 partly to a $36.1m reduction in average loans and a 19-basis-point decline in average loan yield. Loan sales were made to comply with regulator-set concentration guidelines. The remaining $1.1m held-for-sale multifamily loan was expected to be sold in Q3 2018.
  • Management provided no specific earnings or operating guidance. It said the Bank had capacity to grow its held-for-investment portfolio while observing concentration guidelines. Forward-looking statements remain subject to risks and the company undertook no obligation to update them.
  • Risks and watch items include deposit funding: one customer represented approximately 11% of deposits; deposits fell $20.0m while FHLB advances rose $19.0m. Management also noted that regulators may require a higher loan-loss allowance. The company expected adoption of the CECL credit-loss standard to increase the allowance, though the amount was not yet determined. The upcoming lease standard was expected to create a lease liability and right-of-use asset, with potentially minor regulatory-capital effects.
  • Available-for-sale securities had $347k of gross unrealized losses at June 30, primarily attributed to interest-rate movements; management did not consider the losses other-than-temporary. No legal proceedings or new risk factors were reported in this filing.

Most important facts for investors to verify

  • Whether loan growth and portfolio mix can stabilize net interest income and margins as deposit and borrowing costs change.
  • Deposit retention, renewal pricing and reliance on the large depositor, CDARS and FHLB funding.
  • Credit quality trends, especially church and multifamily exposures, TDR performance, collateral values and the adequacy of the allowance.
  • The realized outcome of the expected Q3 sale of the remaining held-for-sale loan, and compliance with loan concentration limits.
  • The eventual CECL allowance impact and the effect of lease-accounting adoption on reported assets, liabilities and regulatory capital.